ジェイファーマ
520A・Growth Market・Pharmaceuticals
ジェイファーマ
520A・Growth Market・Pharmaceuticals
Governance
The company has adopted an Audit and Supervisory Committee structure, with the board comprising 6 directors as of the filing date (including 4 outside directors and 3 audit and supervisory committee members). The audit and supervisory committee members include individuals with experience managing biotech companies as well as qualified certified public accountants and attorneys, and the board of directors has held meetings 25 times per year on record.
Risk Management
The Company has established the "Risk Management and Compliance Regulations" and set up a Risk and Compliance Committee (meeting twice or more per year) chaired by the President and Representative Director. The Board of Directors, the Audit and Supervisory Committee, and internal audit personnel (3 members) collaborate to ensure prompt recognition of material risks and to maintain a system for consultation with experts (attorneys, audit firms, and tax accountants).
Shareholder Returns
The company plans to maintain a no-dividend policy for the time being in order to prioritize investment in research and development, allocating the full amount of retained earnings from profits to research and development. The articles of incorporation stipulate that share buybacks can be carried out flexibly by resolution of the Board of Directors.
Dividend Policy
The company plans to remain dividend-free for the time being in order to pursue active research and development, allocating the full amount of retained earnings from profits to research and development. Dividend decisions will take into account the need to build up retained earnings in preparation for investment in research and development. The articles of incorporation stipulate that the year-end dividend is to be determined by resolution of the general shareholders' meeting, and the interim dividend by resolution of the Board of Directors.
ESG
The company upholds contribution to unmet medical needs as its corporate philosophy and promotes sustainability management through its Risk and Compliance Committee. While it is working to develop its internal environment through human resource development, ensuring diversity, and introducing remote work, quantitative indicators and targets have not yet been set at this time and remain a matter for future consideration.
Last updated: June 24, 2026